Moh'd Khushman, MD

Medical Oncologist

Moh'd Khushman

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108
Siteman Cancer Center at Barnes-Jewish West County Hospital

Siteman Cancer Center at Barnes-Jewish West County Hospital

Medical Office Building 2, 10 Barnes West Drive, Creve Coeur, MO 63141

Expertise & Training

Video thumbnail for Dr. Moh'd Khushman, MD

Watch video on YouTube

Dr. Moh'd Khushman, MD

4 mins

Dr. Moh'd Khushman, MD Associate Professor of Medicine, Division of Medical Oncology, Washington University School of Medicine at Siteman Cancer Center

Clinical Expertise

  • As a member of our stomach cancer specialist team, Dr. Khushman cares for patients diagnosed with stomach cancer and other gastrointestinal cancers through treatment and recovery.

Primary Academic Title

Professor of Medicine, Division of Medical Oncology, WashU Medicine

Board Certification

  • 2011: American Board of Internal Medicine
  • 2015: American Board of Internal Medicine (Hematology)
  • 2015: American Board of Internal Medicine (Medical Oncology)

Training

  • 2008 - 2011: Resident, Internal Medicine, Henry Ford Hospital, Detroit, MI
  • 2011 - 2012: Chief Resident, Internal Medicine, Henry Ford Hospital/Wayne State University, Detroit, MI
  • 2012 - 2015: Fellow, Hematology/Oncology, University of Miami, FL

Education

  • 2006: MD, University of Jordan, Amman

Research & Selected Publications

Research Interests

Molecular profiling of GI malignancies and their clinical applications, biomarkers discovery and their incorporation in investigator-initiated trials, germline pharmacogenomics of DPYD and TYMS genes, the translational impact of exosomes

Research Publications

Ataxia Telangiectasia Mutated (ATM) gene alterations as biomarkers of response to immune checkpoint inhibitors
Authors:

Baral MR, Abushukair H, Abdelrahim M, one or more additional authors omitted Khushman M

Journal & Year:

Immunotherapy | 2025

Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma
Authors:

Lagos G, Groisberg R, Elliott A, one or more additional authors omitted Khushman MM, one or more additional authors omitted Trent JC

Journal & Year:

Clin Cancer Res | 2025

Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literatu…
Authors:

Kim S, Itani M, Liu X, one or more additional authors omitted Khushman M

Journal & Year:

JCO Precis Oncol | 2025

Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
Authors:

Bajpai P, Agarwal S, Afaq F, one or more additional authors omitted Khushman M, Manne U

Journal & Year:

J Exp Clin Cancer Res | 2024

Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Authors:

Khushman MM, Toboni MD, Xiu J, one or more additional authors omitted Powell MA

Journal & Year:

Clin Cancer Res | 2024